Results 171 to 180 of about 2,667 (188)

Ravulizumab Treatment during Pregnancy: A Case Report

Blood
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare chronic blood disorder associated with a significant risk of thrombosis, the leading cause of death in patients (pts) with PNH. In pregnant women, PNH is also associated with increased maternal and fetal complications. While data are available for eculizumab (ECU)
Daniel Knight, Bhumika J Patel
openaire   +1 more source

Mycophenolate-mofetil/ravulizumab/steroids

Reactions Weekly, 2023
openaire   +1 more source

Ravulizumab in neuer Konzentration zugelassen

InFo Hämatologie + Onkologie, 2021
openaire   +1 more source

Ravulizumab for COVID-19 Kidney Injury

Journal of the American Society of Nephrology, 2022
Aliza Anwar Memon, Hasban Ahmed, Andrew M. Siedlecki   +2 more
openaire   +1 more source

PNH: Neue Daten zu Ravulizumab

InFo Hämatologie + Onkologie, 2023
openaire   +1 more source

Ravulizumab auch gegen NMOSD wirksam

InFo Neurologie + Psychiatrie, 2023
openaire   +1 more source

Ravulizumab in patients with generalised myasthenia gravis

Medicom Conference Report AAN 2022, 2022
Tuan Hoang Vu, Michiel Tent
openaire   +1 more source

Keine komplementvermittelten Durchbruchhämolysen mit Ravulizumab

Transfusionsmedizin, 2021
openaire   +1 more source

Ravulizumab effective in AQP4+ NMOSD

Medicom Conference Report AAN 2023, 2023
openaire   +1 more source

Meningococcal vaccine conjugate/ravulizumab

Reactions Weekly, 2019
openaire   +1 more source